From BioHealth I read a very well written article penned recently by Nature staff reporter Erika Check for Wired Magazine. Ms.Check profiles a popular nationalist in India by the name of Khwaja Abdul Hamied,…
From BioHealth Investor It seems like Vertex Pharmaceuticals (VRTX) is the subject of the majority of my articles (link one, two, three to past articles) and for good reasons. VRTX is looking to become…
If you can’t beat them, cry about them. the chairman of Sanofi-Aventis of France recently complained that generic drug companies were making product in poor countries where costs were low and then selling the…
Put back the crash carts. Boston Scientific is up and walking. A sharp decline in coated drug stents, brought on by studies that they may cause heart problems, has not significantly hurts sales. The…
From BioHealth Investor Biotechnology NEURALSTEM INC +19.05% REPROS THERAPEUTICS +16.52% CYTORI THERAPEUTICS +13.83% ADVENTRX PHARMACTL +10.98% ARTES MEDICAL, INC. +9.83% Diagnostic Substances ASPENBIO PHARMA INC +7.66% EPICEPT CORPORATION +7.19% ISTA PHARMACTLS +6.54% THRESHOLD PHARMACEUT…
by H.S. AyoubBioHealthInvestor.com Unless you have been under a rock, and not under a bed cover, you have probably heard of Pfizer’s (PFE) Viagra and ICOS’s (ICOS) Cialis, the erectile dysfunction blockbuster drugs that…
Short interest in Pfizer rose 6.8 million shares to 51.1 million in December. Market fears that generics will eat away at revenues at Big Pharma is not helping. But, Pfizer is unique now. Its…
From BioHealth Investor The following list represents the top ten medical stocks ranked according to Earnings Per Share and Relative Strength by Investor’s Business Daily (12/23/06) scores out of 100 (last week’s rank, change…
From BioHealth Investor Shares of Bentley Pharmaceuticals (BNT) are up more than 13% early Friday as the company announced that its U.S. marketing partner, Perrigo Company, has received marketing approval for simvastatin 5 mg,…
From BioHealth Investor Biotechnology REPROS THERAPEUTICS +30.18% INTERMUNE INC +29.03% EXACT SCIENCES COR +24.59% LA JOLLA PHARMA +10.32% IDM PHARMA INC +9.16% Diagnostic Substances REMOTEMDX INC +12.95% IMMUNOMEDICS INC +7.98% GENE LOGIC INC +4.64%…
From BioHealth Investor Biotechnology PRAECIS PHARMA +144.51% FERMAVIR PHARMACEUTL +28.00% POLYMEDIX INC +23.08% ACCENTIA BIOPHARMACE +17.59% REXAHN PHARMACEUTICL +17.39% Diagnostic Substances IMMUNOMEDICS INC +13.59% AVALON PHARMACEUTIC +12.50% ASPENBIO PHARMA INC +10.84% REMOTEMDX INC +7.75%…
The New York Times hits Lilly (LLY) almost daily with a new article on how the drug company dupped doctors and patients into thinking that its drug for schizophrenia was safe and did not…
From BioHealth Investor Biotechnology VERNALIS PLC ADR +10.67% KOSAN BIOSCIENCES +10.66% OPEXA THERAPEUTICS +10.03% EMERGENT BIOSOLUTION +10.03% I G I INC +9.76% Diagnostic Substances REMOTEMDX INC +9.32% EPICEPT CORPORATION +5.52% ADEZA BIOMEDICAL COR +3.94%…
By Chad Brand of Peridot Capitalist Late Monday drug giant Pfizer (PFE) announced a 21 percent increase in its annual dividend, to $1.16 per share. With the stock trading at $25 and change, the…
From BioHealth Investor Biotechnology HESKA CORPORATION +10.67% IDERA PHARMACEUTICAL +8.76% NUTRITION 21 INC +8.00% METABASIS THERAPEUTI +5.19% CYTORI THERAPEUTICS +4.76% Diagnostic Substances IMMUNOMEDICS INC +11.11% SYNOVICS PHARMACEUTL +6.25% AVALON PHARMACEUTIC +4.93% PRESSURE BIOSCIENC +4.19%…